Lack of association between the haplotype GCC/ATA polymorphism in the IL-10 promoter and SLE risk: Evidence from a meta-analysis

Zeitschrift fur Rheumatologie

Volumn 72, Issue 7, 2013, Pages 705-708

  Wang, B ^a   Fan, Y G ^a   Ye, D Q ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Genetic susceptibility; Interleukin 10; Lupus erythematosus systemic; Polymorphism genetic; Risk assessment

Indexed keywords

ARTICLE; ASIAN; CAUCASIAN; GENE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; INTERLEUKIN 10 GENE; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EVIDENCE-BASED MEDICINE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84883657193     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-013-1158-1     Document Type: Article

References (20)

1. López P, Gutiérrez C, Suárez A (2010) IL-10 and TNFα genotypes in SLE. J Biomed Biotechnol 10, 1-10
2. Eskdale J, Gallagher G, Verweij CL et al (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95(16):9465-9470
3. Lin YJ, Wan L, Huang CM et al (2010) IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 28(3):318-324
4. Rosado S, Rua-Figueroa I, Vargas JA et al (2008) Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 35(3):235-242
5. Hee CS, Gun SC, Naidu R et al (2008) The relationship between single nucleotide polymorphisms of the interleukin-10 gene promoter in systemic lupus erythematosus patients in Malaysia: a pilot study. Inter J Rheumat Diseases 11:148-154
6. Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al (2006) The synergistic effect of FC gamma receptor IIa and interleukin-10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68(5):399-406
7. Hrycek A, Siekiera U, CieÅlik P, Szkróbka W (2005) HLA-DRB1 and-DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol Int 26(1):1-6
8. Guzowski D, Chandrasekaran A, Gawel C et al (2005) Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech 16(2):154-166
9. Suárez A, López P, Mozo L, Gutiérrez C (2005) Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 64(11):1605-1610
10. Linden MW van der, Westendorp RG, Sturk A et al (2000) High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. J Investig Med 48(5):327-334
11. Rood MJ, Keijsers V, Linden MW van der et al (1999) Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 58(2):85-89
12. Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42(9):2017-2018
13. Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41(6):1090-1095
14. Lazarus M, Hajeer AH, Turner D et al (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24(12):2314-2317
15. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10, 101-129
16. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a metaanalysis. Stat Med 21, 1539-1558
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327, 557-560
18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177-178
19. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-728
20. Gibson AW, Edberg JC, Wu J et al (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166, 3915-3922